Atlas FDA

Optune System

FDA premarket approval P100034/S031 · decided 2023-08-14

Approval details

PMA number
P100034
Supplement
S031
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
Optune System
Generic name
Stimulator, low electric field, tumor treatment
Applicant
Novocure, GmbH
Date received
2023-04-28
Decision date
2023-08-14
Days to decision
108 days
Decision code
APPR
Product code
NZK
Advisory committee
Neurology
Expedited review
No
Location
Baar
Statement
Approval for a trade name change from Optune to Optune Gio.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.